DIPENTUM Drug Patent Profile
✉ Email this page to a colleague
When do Dipentum patents expire, and when can generic versions of Dipentum launch?
Dipentum is a drug marketed by Mylan Spclt Viatris and is included in one NDA.
The generic ingredient in DIPENTUM is olsalazine sodium. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the olsalazine sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIPENTUM?
- What are the global sales for DIPENTUM?
- What is Average Wholesale Price for DIPENTUM?
Summary for DIPENTUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 150 |
Patent Applications: | 4,291 |
Drug Prices: | Drug price information for DIPENTUM |
What excipients (inactive ingredients) are in DIPENTUM? | DIPENTUM excipients list |
DailyMed Link: | DIPENTUM at DailyMed |
Pharmacology for DIPENTUM
Drug Class | Aminosalicylate |
US Patents and Regulatory Information for DIPENTUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Spclt Viatris | DIPENTUM | olsalazine sodium | CAPSULE;ORAL | 019715-001 | Jul 31, 1990 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DIPENTUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Spclt Viatris | DIPENTUM | olsalazine sodium | CAPSULE;ORAL | 019715-001 | Jul 31, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DIPENTUM
See the table below for patents covering DIPENTUM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S56154417 | USE OF 3,3'-AZOBIS -(6-HYDROXYBENZOIC ACID) AS DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING IT | ⤷ Sign Up |
Japan | H0148247 | ⤷ Sign Up | |
Australia | 6862481 | ⤷ Sign Up | |
Israel | 62382 | PHARMACEUTICAL COMPOSITIONS CONTAINING 3,3'-AZO-BIS-(6-HYDROXY BENZOIC ACID) | ⤷ Sign Up |
Canada | 1179602 | APPLICATION PHARMACOLOGIQUE DE L'ACIDE 3,3'-AZO-BIS- 6-HYDROXYBENZOIQUE ET COMPOSES PHARMACEUTIQUES LE CONTENANT (USE OF 3,3'-AZO-BIS-(6-HYDROXY BENZOIC ACID) AS A DRUG AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME) | ⤷ Sign Up |
Australia | 549237 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |